Biotech23 hours ago
BB Biotech Accelerates Portfolio Overhaul and Outperforms NAV in Strong Q1 2026
BB Biotech actively restructured its portfolio in early 2026, adding eleven stocks and expanding investment guidelines. Its share price outperformed net asset value, narrowing the valuation...